Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$82.10−1.51 (-1.81%)
Close on Nov 17, 2026Market cap $6.45BP/E –Yield –
Abivax price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Abivax
Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?